• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER TORQVUE DELIVERY SYSTEM; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER TORQVUE DELIVERY SYSTEM; CATHETER, PERCUTANEOUS Back to Search Results
Model Number 9-ITV05F180/60
Device Problem Difficult to Insert (1316)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 06/24/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2020, a 5/4 amplatzer duct occluder i was selected for implant using 5 french delivery sheath.During the procedure, the physician could not advance the device into the hub of the sheath.After multiple attempts, a new 6 french delivery system was selected to successfully deploy the device.The physician reported a significant delay in the procedure leading to an increased amount of blood loss.The patient was reported to be stable.
 
Manufacturer Narrative
Additional information for: g4, g7, h2, h3, h6, and h10.The advancement difficulty was confirmed upon receipt of the device.The distal tubing of the loader was also noted to be 0.005 inches under the specification tolerance, consistent with damage during use.A historical review of complaints was performed, which found the occurrence rate of this failure mode, based on reported events for advancement difficulty, is below that of the expected rate listed within the risk documentation.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.This was inclusive of a go/no go gauge method for measurement of the distal end of the loader tubing.While the root cause of the advancement difficulty in this case could not be definitively determined, further investigation found that ensuring the distal luer of the loader is fully tightened over the male threads of the sheath hub mitigates difficulty advancing from the loader into the sheath.Furthermore, if the shortening of the distal end of the tubing existed during initial attempts to advance the occluder, it may have exacerbated the susceptibility to advancement difficulty due to the interaction between the loader and sheath.A historical analysis found this device family to be within its predicted occurrence rate for this failure and harm.Abbott will continue to monitor this issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER TORQVUE DELIVERY SYSTEM
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10277499
MDR Text Key198921064
Report Number2135147-2020-00302
Device Sequence Number1
Product Code DQY
UDI-Device Identifier00811806010755
UDI-Public00811806010755
Combination Product (y/n)N
PMA/PMN Number
K072313
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2022
Device Model Number9-ITV05F180/60
Device Catalogue Number9-ITV05F180/60
Device Lot Number7301596
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/24/2020
Initial Date FDA Received07/15/2020
Supplement Dates Manufacturer Received12/16/2020
Supplement Dates FDA Received12/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age5 MO
Patient Weight6
-
-